Weekend effect

Trevena, Inc. Announces Publication Highlighting OLINVYK™ Respiratory Safety Data in High-Risk Patients in Pain & Therapy

Retrieved on: 
Thursday, January 28, 2021

Pain management with IV opioids remains a key strategy for optimal analgesic management in the postoperative setting.

Key Points: 
  • Pain management with IV opioids remains a key strategy for optimal analgesic management in the postoperative setting.
  • These findings are important and will serve as useful information for clinicians as they consider treatment options for their challenging patients.
  • Elderly patients ( 65 years) demonstrated no statistically significant difference in OIRD incidence compared to younger patients (10.8% vs. 15.1%, p=0.11).
  • Obese patients (BMI 30) demonstrated no statistically significant difference in OIRD incidence compared to non-obese patients (14.0% vs. 13.4%, p=0.80).

CCNY's Keith Gandal finds COVID-19 related deaths are lower on the weekend

Retrieved on: 
Thursday, August 13, 2020

According to their research, the average death toll from COVID-19 in the U.S. is 901.4 deaths on Saturdays, 682.4 on Sundays, and 699.1 on Mondays.

Key Points: 
  • According to their research, the average death toll from COVID-19 in the U.S. is 901.4 deaths on Saturdays, 682.4 on Sundays, and 699.1 on Mondays.
  • Historical research shows that there is such a weekend effect for overall deaths, but it is weaker still.
  • "It seems probable that something social is going on with overall U.S. COVID-19 deaths, corresponding to differing behaviors and attitudes tied to different days of the week," said Gandal.
  • However, the weekend effect on COVID-19 deaths does not exist in New York City.

Early Research Doubts Benefit of COVID-19 Drug Treatment

Retrieved on: 
Monday, May 18, 2020

Overall in-hospital mortality was reported at 20.3%, with no significant benefit associated with either drug or when both drugs were administered together.

Key Points: 
  • Overall in-hospital mortality was reported at 20.3%, with no significant benefit associated with either drug or when both drugs were administered together.
  • Researchers found cardiac arrest significantly more likely among patients receiving both drugs when compared to patients receiving neither drug.
  • This increase risk was maintained after adjustment for level of illness upon hospital admission (among other factors).
  • For 35 years IPRO has made creative use of clinical expertise, emerging technology and data solutions to make the healthcare system work better.

Working-Age COVID-19 Patients Are Nearly Four to Five Times as Likely to Survive Hospitalization Than Patients 76 and Older, Real-World Data Analysis Shows

Retrieved on: 
Friday, May 15, 2020

Agilum's real-world data analysis also shows that age and gender are independent and significant mortality risk factors among hospitalized COVID-19 patients.

Key Points: 
  • Agilum's real-world data analysis also shows that age and gender are independent and significant mortality risk factors among hospitalized COVID-19 patients.
  • Older patients are at greater risk of death than younger patients, and men are at greater risk of death, regardless of age, than women among the U.S. population studied.
  • The analysis is made possible by Agilum's longitudinal, real-world database comprised of more than 140 million de-identified patients, including 34,000+ hospitalized COVID-19 patients across more than 450 U.S. hospitals.
  • "Age, independent of gender, and gender, independent of age, are both powerful predictors of death for hospitalized COVID-19 patients.

Asian and Hispanic Residents Have Highest COVID-19 Diagnosis Rates, While Black Patients Experience Highest Mortality Rates - NJHA Analysis

Retrieved on: 
Thursday, May 7, 2020

NJHA's analysis, based on hospital discharge data, shows that Asian and Hispanic individuals have higher age-adjusted diagnosis rates, while black patients have the highest age-adjusted mortality rate.

Key Points: 
  • NJHA's analysis, based on hospital discharge data, shows that Asian and Hispanic individuals have higher age-adjusted diagnosis rates, while black patients have the highest age-adjusted mortality rate.
  • Hispanics had the second-highest age-adjusted diagnosis rate, at 20.3 per hundred population for males and 17.6 per hundred for females.
  • The most impacted communities differ when examining those with the highest age-adjusted COVID-19 mortality rate.
  • The analysis showed:
    White patients followed, with a 7.9 per hundred population mortality rate for males and 5.7 per hundred population for females.

Kite and the CIBMTR® Present Positive Findings From Real-World Use of Yescarta® (Axicabtagene Ciloleucel) in Relapsed or Refractory Large B-Cell Lymphoma

Retrieved on: 
Monday, December 9, 2019

ORR was similar among older and younger patients (92 percent in patients 65 years versus 80 percent in patients

Key Points: 
  • ORR was similar among older and younger patients (92 percent in patients 65 years versus 80 percent in patients
  • With more than 85 centers authorized to treat patients with Yescarta, these post-approval results reinforce its potentially transformative role in third line or later relapsed or refractory large B-cell lymphoma, said Christi Shaw, Chief Executive Officer of Kite.
  • Neurologic toxicities, including fatal or life-threatening reactions, occurred in patients receiving Yescarta, including concurrently with CRS or after CRS resolution.
  • Yescarta is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the Yescarta REMS.

European Results From Global ETNA-AF Registry Show Low Bleeding and Low Cardiovascular Event Rates in Elderly NVAF Patients on LIXIANA®▼ (edoxaban)

Retrieved on: 
Saturday, October 12, 2019

Rates of systemic embolic events (SEE) and myocardial infarction (MI) were generally low.

Key Points: 
  • Rates of systemic embolic events (SEE) and myocardial infarction (MI) were generally low.
  • All-cause mortality occurred in 425 (3.55%) patients and cardiovascular mortality occurred in 200 (1.67%) patients.
  • While rates of stroke, bleeding and all-cause and cardiovascular mortality increased with age, an age-related increase in ICH was not apparent and rates were low in each age group.
  • "In routine clinical practice, the rates of major and clinically-relevant non-major (CRNM) bleeding in elderly edoxaban-treated patients were lower than those observed in clinical trial settings.